Outcomes from the TITAN Study in mCSPC

William Oh, MD, Chief of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai discusses the outcomes of the TITAN study in metastatic castration-sensitive prostate cancer (mCSPC).<br />... Author: obr Added: 07/01/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts